Subgroup analysis of patients participating in the AETHERA trial: A randomized, double-blind, placebo-controlled phase 3 study of brentuximab vedotin in patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma Meeting Abstract
| Authors: | Sureda, A.; Walewski, J.; Nadamanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M.; Chen, A.; Stiff, P.; Viviani, S.; Carella, A.; Osmanov, D.; Bachanova, V.; Sweetenham, J.; Lee, S. Y.; Larsen, E.; Hunder, N.; Moskowitz, H. |
| Abstract Title: | Subgroup analysis of patients participating in the AETHERA trial: A randomized, double-blind, placebo-controlled phase 3 study of brentuximab vedotin in patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma |
| Meeting Title: | 41st Annual Meeting of the European Society for Blood and Marrow Transplantation |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 50 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Mar 22-25 |
| Meeting Location: | Istanbul, Turkey |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2015-03-01 |
| Start Page: | S65 |
| End Page: | S66 |
| Language: | English |
| ACCESSION: | WOS:000351632900113 |
| PROVIDER: | wos |
| DOI: | 10.1038/bmt.2015.27 |
| Notes: | Meeting Abstract: O112 -- 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation -- MAR 22-25, 2015 -- Istanbul, TURKEY -- 1 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work